US20120165955A1 - Intragastric Prosthesis for the Treatment of Morbid Obesity - Google Patents
Intragastric Prosthesis for the Treatment of Morbid Obesity Download PDFInfo
- Publication number
- US20120165955A1 US20120165955A1 US13/408,578 US201213408578A US2012165955A1 US 20120165955 A1 US20120165955 A1 US 20120165955A1 US 201213408578 A US201213408578 A US 201213408578A US 2012165955 A1 US2012165955 A1 US 2012165955A1
- Authority
- US
- United States
- Prior art keywords
- filaments
- stomach
- weave
- esophagus
- dimensions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0036—Intragastrical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
Definitions
- the present invention pertains to a resilient, flexible, compressible, bio-compatible prosthesis insertable into the stomach to effect weight loss over a controlled period.
- Surgical treatments include gastroplasty to restrict the capacity of the stomach to hold large amounts of food, such as by stapling or “gastric banding.”
- Other surgical procedures include gastric bypass and gastric “balloons” which, when deflated, may be inserted into the stomach and then are distended by filling with saline solution.
- the present invention provides a novel system for treatment of morbid obesity by use of a bioabsorbable gastric prosthesis placed in the stomach through a minimally invasive procedure.
- the prosthesis takes up space in the stomach so that the stomach can hold a limited amount of food, and preferably exerts pressure on the upper fundus to create a sensation of being full.
- the material of the prosthesis can be selected to degrade over a predetermined period and pass out of the patient without additional intervention.
- the prosthesis is a porous weave of bioabsorbable filaments having an open mesh configuration.
- the prosthesis can be formed from a cylindrical stent, such as by reverting the ends of the cylinder and joining them at the center.
- the filaments preferably have memory characteristics tending to maintain an oblate shape with sufficient resiliency and softness so as not to unduly interfere with normal flexing of the stomach or cause abrasion of the mucus coat constituting the inner lining of the stomach.
- the prosthesis may be free floating in the stomach, but is shaped so as to be biased against the upper fundus, or it may be tacked in position adjacent to the fundus by bioabsorbable sutures.
- FIG. 1 is a somewhat diagrammatic elevation of a stomach and adjacent parts of the alimentary canal, with the wall adjacent to the viewer partially broken away to reveal an intragastric prosthesis in accordance with the present invention
- FIG. 2 is a side elevation of a cylindrical stent from which a prosthesis in accordance with the present invention may be formed;
- FIG. 3 is a side elevation of a prosthesis in accordance with the present invention, formed from the stent of FIG. 2 ;
- FIG. 4 is a diagrammatic elevation corresponding to FIG. 1 , illustrating insertion of a prosthesis in accordance with the present invention through the esophagus and into the stomach.
- the present invention provides a volume-filling prosthesis insertable into the stomach for treatment of morbid obesity by taking up space in the stomach to reduce its capacity and by exerting pressure to create a sensation of being full, particularly on the upper fundus.
- FIG. 1 illustrates a central portion of the alimentary canal including the distal segment of the esophagus 10 , the stomach 12 , and the duodenum 14 (proximate segment of the small intestine).
- the esophagus 10 opens into the stomach 12 toward the top of the lesser curvature 16 adjacent to the fundus 18 .
- the pyloric part 20 of the stomach leads to the duodenum by way of the gastric outlet or pylorus 22 which forms the distal aperture of the stomach and has an enclosing circular layer of muscle which is normally contracted to close the aperture but which relaxes to provide an open but restricted passage.
- representative dimensions for the stomach are approximately 8 cm long (fundus to pylorus) by 5 cm wide (greatest distance between lesser and greater curvatures), with the esophageal opening being approximately 2 cm in diameter and the pylorus having a maximum open diameter of about 2 cm.
- an oblate, volume-filling prosthesis 24 is held within the stomach, sized for reception in the proximate portion adjacent to the opening of the esophagus and fundus.
- Such prosthesis preferably is a porous body formed of a loose weave of thin polymer filaments 26 , having large spaces between filaments for an open area of at least about 80%, preferably more than 90%, so as not to impede the flow of gastric juices or other functioning in the stomach.
- the filaments 26 have substantial memory characteristics for maintaining the desired oblate shape and size.
- the filaments preferably are sufficiently soft and flexible to avoid abrasion of the mucus coat forming the inner lining of the stomach and to enable normal flexing and shape changes.
- the size of the prosthesis 24 is substantially greater than the opening of the esophagus, at least about 3 cm in the narrowest dimension, preferably at least about 4 cm.
- the longer dimension of the oblate prosthesis is greater than 4 cm, preferably at least about 5 cm to prevent the prosthesis from free movement within the stomach.
- the size and shape of the prosthesis tend to maintain it in the position indicated in FIG. 1 , adjacent to the fundus 18 and remote from the pyloric part 20 .
- the prosthesis occupies a substantial portion of the volume of the stomach, preferably approximately one-half the volume, the prosthesis does not interfere with normal digestion of food, such as by gastric juices (hydrochloric acid and digestive enzymes) nor with passage of food through the pyloric part 20 and its opening 22 to the duodenum 14 .
- the prosthesis can be formed from a substantially cylindrical stent 28 having the desired porous weave and large open area.
- the filaments 26 and weave pattern are selected to achieve memory characteristics biasing the prosthesis to the cylindrical condition shown.
- the opposite ends 30 of the stent are reverted, the end portions are rolled inward, and the ends are secured together such as by suturing.
- a disk of the same pattern and material can be used in securing the reverted ends together. The resiliency of the filaments tends to bulge the resulting prosthesis 26 outward to the desired oblate shape.
- stent 28 in the condition shown in FIG. 2 can be approximately 2-3 cm in diameter and approximately 8-10 cm long, in a representative embodiment.
- the filaments can have a diameter of about 0.010 inch to about 0.25 inch.
- the filaments may be coated or impregnated with other treating agents, such as appetite suppressants, or agents to decrease the likelihood of gastric problems, such as ulcers, due to the presence of a foreign object. However, such problems are unlikely due to the biocompatible nature and the resilient flexibility of the prosthesis.
- the filaments 26 be formed of a bioabsorbable polymer such as a polyglycolic acid polymer or polylactic acid polymer. Similar materials are used for some bioabsorbable sutures having “forgiving” memory characteristics and sufficient “softness” that tissue abrasion is inhibited.
- the absorption characteristics of the filaments 26 can be selected to achieve disintegration of the prosthesis 26 within the range of three months to two years, depending on the severity of obesity. In the preferred embodiment, the prosthesis will absorb and pass naturally from the stomach approximately 6 months after deployment.
- Nonbioabsorbable materials may be used, such as Nitinol, which exhibit the desired springiness but which would require that the prosthesis be retrieved.
- An advantage of the preferred, bioabsorbable embodiment of the invention is that delivery can be through the esophagus, with no additional intervention being required.
- the prosthesis 26 can be compressed to a generally cylindrical shape having a diameter of no more than about 2 cm such that the compressed prosthesis can be carried in a short (approximately 5 cm to 6 cm long) loading tube 32 .
- the loading tube can be advanced along the esophagus by a central tube 34 of smaller diameter, under the visualization allowed by a conventional endoscope 36 .
- the tube 34 can enclose a core wire 38 to actuate a pusher mechanism 40 for ejecting the prosthesis 26 when the opening of the esophagus into the stomach has been reached.
- the endoscope and deployment mechanism can then be retracted.
- the prosthesis be sized for self-retention in the desired position in the stomach, it also may be secured in position by a few sutures applied endoscopically, preferably in or adjacent to the fundus area of the stomach.
Abstract
Description
- This application is a continuation of application Ser. No. 10/795,491, filed Mar. 8, 2004, now U.S. Pat. No. 7,090,699, which is a continuation of application Ser. No. 10/057,469, filed Jan. 25, 2002, now U.S. Pat. No. 6,755,869, which is a continuation of application Ser. No. 10/007,819, filed Nov. 9, 2001, now abandoned, the disclosures of which are hereby expressly incorporated by reference.
- The present invention pertains to a resilient, flexible, compressible, bio-compatible prosthesis insertable into the stomach to effect weight loss over a controlled period.
- The incidence of obesity and its associated health-related problems have reached epidemic proportions in the United States. See, for example, P. C. Mun et al., “Current Status of Medical and Surgical Therapy for Obesity” Gastroenterology 120:669-681 (2001). Recent investigations suggest that the causes of obesity involve a complex interplay of genetic, environmental, psycho-behavioral, endocrine, metabolic, cultural, and socio-economic factors. Severe obesity is frequently associated with significant comorbid medical conditions, including coronary artery disease, hypertension, type II diabetes mellitus, gallstones, nonalcoholic steatohepatitis, pulmonary hypertension, and sleep apnea.
- Estimates of the incidence of morbid obesity are approximately 2% of the U.S. population and 0.5% worldwide. Current treatments range from diet, exercise, behavioral modification, and pharmacotherapy to various types of surgery, with varying risks and efficacy. In general, nonsurgical modalities, although less invasive, achieve only relatively short-term and limited weight loss in most patients. Surgical treatments include gastroplasty to restrict the capacity of the stomach to hold large amounts of food, such as by stapling or “gastric banding.” Other surgical procedures include gastric bypass and gastric “balloons” which, when deflated, may be inserted into the stomach and then are distended by filling with saline solution.
- The need exists for cost effective, less invasive interventions for the treatment of morbid obesity.
- This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This summary is not intended to identify key features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
- The present invention provides a novel system for treatment of morbid obesity by use of a bioabsorbable gastric prosthesis placed in the stomach through a minimally invasive procedure. The prosthesis takes up space in the stomach so that the stomach can hold a limited amount of food, and preferably exerts pressure on the upper fundus to create a sensation of being full. The material of the prosthesis can be selected to degrade over a predetermined period and pass out of the patient without additional intervention.
- In the preferred embodiment, the prosthesis is a porous weave of bioabsorbable filaments having an open mesh configuration. The prosthesis can be formed from a cylindrical stent, such as by reverting the ends of the cylinder and joining them at the center. The filaments preferably have memory characteristics tending to maintain an oblate shape with sufficient resiliency and softness so as not to unduly interfere with normal flexing of the stomach or cause abrasion of the mucus coat constituting the inner lining of the stomach. The prosthesis may be free floating in the stomach, but is shaped so as to be biased against the upper fundus, or it may be tacked in position adjacent to the fundus by bioabsorbable sutures.
- The foregoing aspects and many of the attendant advantages of this invention will become more readily appreciated as the same become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings, wherein:
-
FIG. 1 is a somewhat diagrammatic elevation of a stomach and adjacent parts of the alimentary canal, with the wall adjacent to the viewer partially broken away to reveal an intragastric prosthesis in accordance with the present invention; -
FIG. 2 is a side elevation of a cylindrical stent from which a prosthesis in accordance with the present invention may be formed; -
FIG. 3 is a side elevation of a prosthesis in accordance with the present invention, formed from the stent ofFIG. 2 ; and -
FIG. 4 is a diagrammatic elevation corresponding toFIG. 1 , illustrating insertion of a prosthesis in accordance with the present invention through the esophagus and into the stomach. - The present invention provides a volume-filling prosthesis insertable into the stomach for treatment of morbid obesity by taking up space in the stomach to reduce its capacity and by exerting pressure to create a sensation of being full, particularly on the upper fundus.
-
FIG. 1 illustrates a central portion of the alimentary canal including the distal segment of theesophagus 10, thestomach 12, and the duodenum 14 (proximate segment of the small intestine). Theesophagus 10 opens into thestomach 12 toward the top of thelesser curvature 16 adjacent to thefundus 18. Thepyloric part 20 of the stomach leads to the duodenum by way of the gastric outlet orpylorus 22 which forms the distal aperture of the stomach and has an enclosing circular layer of muscle which is normally contracted to close the aperture but which relaxes to provide an open but restricted passage. Although subject to substantial variation in different individuals, representative dimensions for the stomach are approximately 8 cm long (fundus to pylorus) by 5 cm wide (greatest distance between lesser and greater curvatures), with the esophageal opening being approximately 2 cm in diameter and the pylorus having a maximum open diameter of about 2 cm. - In accordance with the present invention, an oblate, volume-
filling prosthesis 24 is held within the stomach, sized for reception in the proximate portion adjacent to the opening of the esophagus and fundus. Such prosthesis preferably is a porous body formed of a loose weave ofthin polymer filaments 26, having large spaces between filaments for an open area of at least about 80%, preferably more than 90%, so as not to impede the flow of gastric juices or other functioning in the stomach. Thefilaments 26 have substantial memory characteristics for maintaining the desired oblate shape and size. However, the filaments preferably are sufficiently soft and flexible to avoid abrasion of the mucus coat forming the inner lining of the stomach and to enable normal flexing and shape changes. The size of theprosthesis 24 is substantially greater than the opening of the esophagus, at least about 3 cm in the narrowest dimension, preferably at least about 4 cm. The longer dimension of the oblate prosthesis is greater than 4 cm, preferably at least about 5 cm to prevent the prosthesis from free movement within the stomach. The size and shape of the prosthesis tend to maintain it in the position indicated inFIG. 1 , adjacent to thefundus 18 and remote from thepyloric part 20. Thus, while the prosthesis occupies a substantial portion of the volume of the stomach, preferably approximately one-half the volume, the prosthesis does not interfere with normal digestion of food, such as by gastric juices (hydrochloric acid and digestive enzymes) nor with passage of food through thepyloric part 20 and its opening 22 to theduodenum 14. - With reference to
FIG. 2 , the prosthesis can be formed from a substantiallycylindrical stent 28 having the desired porous weave and large open area. Thefilaments 26 and weave pattern are selected to achieve memory characteristics biasing the prosthesis to the cylindrical condition shown. In the preferred embodiment, theopposite ends 30 of the stent are reverted, the end portions are rolled inward, and the ends are secured together such as by suturing. Alternatively, a disk of the same pattern and material can be used in securing the reverted ends together. The resiliency of the filaments tends to bulge theresulting prosthesis 26 outward to the desired oblate shape. - Prior to reversion of the ends,
stent 28 in the condition shown inFIG. 2 can be approximately 2-3 cm in diameter and approximately 8-10 cm long, in a representative embodiment. The filaments can have a diameter of about 0.010 inch to about 0.25 inch. The filaments may be coated or impregnated with other treating agents, such as appetite suppressants, or agents to decrease the likelihood of gastric problems, such as ulcers, due to the presence of a foreign object. However, such problems are unlikely due to the biocompatible nature and the resilient flexibility of the prosthesis. - It is preferred that the
filaments 26 be formed of a bioabsorbable polymer such as a polyglycolic acid polymer or polylactic acid polymer. Similar materials are used for some bioabsorbable sutures having “forgiving” memory characteristics and sufficient “softness” that tissue abrasion is inhibited. The absorption characteristics of thefilaments 26 can be selected to achieve disintegration of theprosthesis 26 within the range of three months to two years, depending on the severity of obesity. In the preferred embodiment, the prosthesis will absorb and pass naturally from the stomach approximately 6 months after deployment. - Nonbioabsorbable materials may be used, such as Nitinol, which exhibit the desired springiness but which would require that the prosthesis be retrieved. An advantage of the preferred, bioabsorbable embodiment of the invention is that delivery can be through the esophagus, with no additional intervention being required.
- With reference to
FIG. 4 , preferably from the condition shown inFIG. 3 , theprosthesis 26 can be compressed to a generally cylindrical shape having a diameter of no more than about 2 cm such that the compressed prosthesis can be carried in a short (approximately 5 cm to 6 cm long)loading tube 32. The loading tube can be advanced along the esophagus by acentral tube 34 of smaller diameter, under the visualization allowed by aconventional endoscope 36. Thetube 34 can enclose acore wire 38 to actuate apusher mechanism 40 for ejecting theprosthesis 26 when the opening of the esophagus into the stomach has been reached. The endoscope and deployment mechanism can then be retracted. - While the preferred embodiment of the invention has been illustrated and described, it will be appreciated that various changes can be made therein without departing from the spirit and scope of the invention. For example, while it is preferred that the prosthesis be sized for self-retention in the desired position in the stomach, it also may be secured in position by a few sutures applied endoscopically, preferably in or adjacent to the fundus area of the stomach.
Claims (23)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/408,578 US20120165955A1 (en) | 2001-11-09 | 2012-02-29 | Intragastric Prosthesis for the Treatment of Morbid Obesity |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US781901A | 2001-11-09 | 2001-11-09 | |
US10/057,469 US6755869B2 (en) | 2001-11-09 | 2002-01-25 | Intragastric prosthesis for the treatment of morbid obesity |
US10/795,491 US7090699B2 (en) | 2001-11-09 | 2004-03-08 | Intragastric prosthesis for the treatment of morbid obesity |
US11/503,538 US7799088B2 (en) | 2001-11-09 | 2006-08-10 | Intragastric prosthesis for the treatment of morbid obesity |
US12/870,977 US8142514B2 (en) | 2001-11-09 | 2010-08-30 | Intragastric prosthesis for the treatment of morbid obesity |
US13/408,578 US20120165955A1 (en) | 2001-11-09 | 2012-02-29 | Intragastric Prosthesis for the Treatment of Morbid Obesity |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/870,977 Continuation US8142514B2 (en) | 2001-11-09 | 2010-08-30 | Intragastric prosthesis for the treatment of morbid obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120165955A1 true US20120165955A1 (en) | 2012-06-28 |
Family
ID=21728281
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/057,469 Expired - Lifetime US6755869B2 (en) | 2001-11-09 | 2002-01-25 | Intragastric prosthesis for the treatment of morbid obesity |
US10/795,491 Expired - Fee Related US7090699B2 (en) | 2001-11-09 | 2004-03-08 | Intragastric prosthesis for the treatment of morbid obesity |
US11/503,538 Expired - Fee Related US7799088B2 (en) | 2001-11-09 | 2006-08-10 | Intragastric prosthesis for the treatment of morbid obesity |
US12/870,977 Expired - Lifetime US8142514B2 (en) | 2001-11-09 | 2010-08-30 | Intragastric prosthesis for the treatment of morbid obesity |
US13/408,578 Abandoned US20120165955A1 (en) | 2001-11-09 | 2012-02-29 | Intragastric Prosthesis for the Treatment of Morbid Obesity |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/057,469 Expired - Lifetime US6755869B2 (en) | 2001-11-09 | 2002-01-25 | Intragastric prosthesis for the treatment of morbid obesity |
US10/795,491 Expired - Fee Related US7090699B2 (en) | 2001-11-09 | 2004-03-08 | Intragastric prosthesis for the treatment of morbid obesity |
US11/503,538 Expired - Fee Related US7799088B2 (en) | 2001-11-09 | 2006-08-10 | Intragastric prosthesis for the treatment of morbid obesity |
US12/870,977 Expired - Lifetime US8142514B2 (en) | 2001-11-09 | 2010-08-30 | Intragastric prosthesis for the treatment of morbid obesity |
Country Status (1)
Country | Link |
---|---|
US (5) | US6755869B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120004590A1 (en) * | 2003-01-16 | 2012-01-05 | Barosense, Inc | Satiation pouches and methods of use |
Families Citing this family (203)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
AU6299401A (en) * | 2000-05-08 | 2001-11-20 | Qtl Biosystems Llc | Improvements to the fluorescent polymer-qtl approach to biosensing |
ES2435094T3 (en) | 2000-05-19 | 2013-12-18 | C.R. Bard, Inc. | Device and method of tissue capture and suturing |
US7033373B2 (en) | 2000-11-03 | 2006-04-25 | Satiety, Inc. | Method and device for use in minimally invasive placement of space-occupying intragastric devices |
EP1414378B1 (en) * | 2001-05-17 | 2008-10-08 | Wilson-Cook Medical Inc. | Intragastric device for treating obesity |
US6558400B2 (en) | 2001-05-30 | 2003-05-06 | Satiety, Inc. | Obesity treatment tools and methods |
CN101810521B (en) | 2001-08-27 | 2015-05-13 | 辛尼科有限责任公司 | Satiation devices and methods |
US7097665B2 (en) | 2003-01-16 | 2006-08-29 | Synecor, Llc | Positioning tools and methods for implanting medical devices |
US6675809B2 (en) | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
US6755869B2 (en) * | 2001-11-09 | 2004-06-29 | Boston Scientific Corporation | Intragastric prosthesis for the treatment of morbid obesity |
US7146984B2 (en) * | 2002-04-08 | 2006-12-12 | Synecor, Llc | Method and apparatus for modifying the exit orifice of a satiation pouch |
US6773440B2 (en) * | 2002-07-02 | 2004-08-10 | Satiety, Inc. | Method and device for use in tissue approximation and fixation |
US6746460B2 (en) | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
US7214233B2 (en) | 2002-08-30 | 2007-05-08 | Satiety, Inc. | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach |
US7033384B2 (en) | 2002-08-30 | 2006-04-25 | Satiety, Inc. | Stented anchoring of gastric space-occupying devices |
US7220237B2 (en) | 2002-10-23 | 2007-05-22 | Satiety, Inc. | Method and device for use in endoscopic organ procedures |
US7740624B2 (en) * | 2002-11-04 | 2010-06-22 | Aspiration Medical Technology, Llc | Method for treating obesity by extracting food |
US20040220516A1 (en) * | 2002-11-04 | 2004-11-04 | Stephen Solomon | Food extraction apparatus and method |
US7815629B2 (en) | 2002-11-04 | 2010-10-19 | Deka Products Limited Partnership | Apparatus for treating obesity by extracting food |
US9055995B2 (en) * | 2002-11-04 | 2015-06-16 | Aspire Bariatrics, Inc. | Method for treating obesity by extracting food |
EP1569582B1 (en) | 2002-12-02 | 2017-05-31 | GI Dynamics, Inc. | Bariatric sleeve |
US7608114B2 (en) | 2002-12-02 | 2009-10-27 | Gi Dynamics, Inc. | Bariatric sleeve |
US7695446B2 (en) | 2002-12-02 | 2010-04-13 | Gi Dynamics, Inc. | Methods of treatment using a bariatric sleeve |
US7025791B2 (en) | 2002-12-02 | 2006-04-11 | Gi Dynamics, Inc. | Bariatric sleeve |
US7678068B2 (en) | 2002-12-02 | 2010-03-16 | Gi Dynamics, Inc. | Atraumatic delivery devices |
US7291160B2 (en) * | 2003-03-17 | 2007-11-06 | Delegge Rebecca | Intragastric catheter |
US7175638B2 (en) | 2003-04-16 | 2007-02-13 | Satiety, Inc. | Method and devices for modifying the function of a body organ |
US8821521B2 (en) * | 2003-07-28 | 2014-09-02 | Baronova, Inc. | Gastro-intestinal device and method for treating addiction |
US9700450B2 (en) | 2003-07-28 | 2017-07-11 | Baronova, Inc. | Devices and methods for gastrointestinal stimulation |
US20090259236A2 (en) * | 2003-07-28 | 2009-10-15 | Baronova, Inc. | Gastric retaining devices and methods |
US9498366B2 (en) * | 2003-07-28 | 2016-11-22 | Baronova, Inc. | Devices and methods for pyloric anchoring |
US6994095B2 (en) * | 2003-07-28 | 2006-02-07 | Medventure Associates Iv | Pyloric valve corking device and method |
US8048169B2 (en) * | 2003-07-28 | 2011-11-01 | Baronova, Inc. | Pyloric valve obstructing devices and methods |
AU2004266574B2 (en) | 2003-08-13 | 2010-11-04 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compressive device for percutaneous treatment of obesity |
US8206456B2 (en) | 2003-10-10 | 2012-06-26 | Barosense, Inc. | Restrictive and/or obstructive implant system for inducing weight loss |
US20050247320A1 (en) | 2003-10-10 | 2005-11-10 | Stack Richard S | Devices and methods for retaining a gastro-esophageal implant |
US7914543B2 (en) | 2003-10-14 | 2011-03-29 | Satiety, Inc. | Single fold device for tissue fixation |
US7097650B2 (en) * | 2003-10-14 | 2006-08-29 | Satiety, Inc. | System for tissue approximation and fixation |
US20050085787A1 (en) * | 2003-10-17 | 2005-04-21 | Laufer Michael D. | Minimally invasive gastrointestinal bypass |
EP1708655A1 (en) | 2003-12-09 | 2006-10-11 | GI Dynamics, Inc. | Apparatus to be anchored within the gastrointestinal tract and anchoring method |
US8057420B2 (en) | 2003-12-09 | 2011-11-15 | Gi Dynamics, Inc. | Gastrointestinal implant with drawstring |
US20050177176A1 (en) * | 2004-02-05 | 2005-08-11 | Craig Gerbi | Single-fold system for tissue approximation and fixation |
EP1713402B1 (en) | 2004-02-13 | 2018-07-04 | Ethicon Endo-Surgery, Inc. | Device for reducing stomach volume |
EP1725194B1 (en) | 2004-02-27 | 2018-01-17 | Ethicon Endo-Surgery, Inc. | Methods and devices for reducing stomach volume |
US8628547B2 (en) | 2004-03-09 | 2014-01-14 | Ethicon Endo-Surgery, Inc. | Devices and methods for placement of partitions within a hollow body organ |
US8449560B2 (en) | 2004-03-09 | 2013-05-28 | Satiety, Inc. | Devices and methods for placement of partitions within a hollow body organ |
US8252009B2 (en) | 2004-03-09 | 2012-08-28 | Ethicon Endo-Surgery, Inc. | Devices and methods for placement of partitions within a hollow body organ |
US9028511B2 (en) | 2004-03-09 | 2015-05-12 | Ethicon Endo-Surgery, Inc. | Devices and methods for placement of partitions within a hollow body organ |
WO2006049725A2 (en) * | 2004-03-23 | 2006-05-11 | Minimus Surgical Systems | Surgical systems and devices to enhance gastric restriction therapies |
US20080071306A1 (en) * | 2004-03-23 | 2008-03-20 | Michael Gertner | Extragastric Balloon With Attachment Tabs |
WO2007067206A2 (en) * | 2005-05-10 | 2007-06-14 | Michael Gertner | Obesity treatment systems |
US20050228415A1 (en) * | 2004-03-23 | 2005-10-13 | Michael Gertner | Methods and devices for percutaneous, non-laparoscopic treatment of obesity |
US20060142790A1 (en) * | 2004-03-23 | 2006-06-29 | Michael Gertner | Methods and devices to facilitate connections between body lumens |
US20060195139A1 (en) * | 2004-03-23 | 2006-08-31 | Michael Gertner | Extragastric devices and methods for gastroplasty |
US7255675B2 (en) * | 2004-03-23 | 2007-08-14 | Michael Gertner | Devices and methods to treat a patient |
US7946976B2 (en) | 2004-03-23 | 2011-05-24 | Michael Gertner | Methods and devices for the surgical creation of satiety and biofeedback pathways |
US20070233170A1 (en) * | 2004-03-23 | 2007-10-04 | Michael Gertner | Extragastric Balloon |
CA2561193A1 (en) | 2004-03-26 | 2005-10-20 | Satiety, Inc. | Systems and methods for treating obesity |
EP1740132B1 (en) * | 2004-04-26 | 2014-12-31 | Synecor, LLC | Restrictive and/or obstructive implant for inducing weight loss |
WO2005107641A2 (en) * | 2004-05-03 | 2005-11-17 | Fulfillium, Inc. | Method and system for gastric volume control |
WO2005112822A1 (en) * | 2004-05-14 | 2005-12-01 | C. R. Bard, Inc. | Gastric balloon devices and methods of use |
TWI280383B (en) * | 2004-06-29 | 2007-05-01 | Japan Ae Power Systems Corp | Partial discharge detecting sensor, and detecting device, and gas insulated electric apparatus provided with a partial discharge detecting sensor |
US7837643B2 (en) | 2004-07-09 | 2010-11-23 | Gi Dynamics, Inc. | Methods and devices for placing a gastrointestinal sleeve |
US8172857B2 (en) | 2004-08-27 | 2012-05-08 | Davol, Inc. | Endoscopic tissue apposition device and method of use |
AU2005287010B2 (en) | 2004-09-17 | 2010-04-15 | Gi Dynamics, Inc. | Gastrointestinal anchor |
ES2582334T3 (en) | 2004-10-15 | 2016-09-12 | Bfkw, Llc | Bariatric device |
KR101696006B1 (en) | 2004-10-15 | 2017-01-13 | 비에프케이더블유, 엘엘씨 | Bariatric device and method for recipient with altered anatomy |
US7347868B2 (en) * | 2004-10-26 | 2008-03-25 | Baronova, Inc. | Medical device delivery catheter |
US7305993B2 (en) * | 2004-10-26 | 2007-12-11 | Medtronic, Inc. | Implantation of tissue bulking devices |
US20060106288A1 (en) | 2004-11-17 | 2006-05-18 | Roth Alex T | Remote tissue retraction device |
US9456915B2 (en) | 2004-11-19 | 2016-10-04 | Fulfilium, Inc. | Methods, devices, and systems for obesity treatment |
US8070807B2 (en) | 2004-11-19 | 2011-12-06 | Fulfillium, Inc. | Wireless breach detection |
US7771382B2 (en) | 2005-01-19 | 2010-08-10 | Gi Dynamics, Inc. | Resistive anti-obesity devices |
US7699863B2 (en) * | 2005-03-01 | 2010-04-20 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
IL167194A (en) * | 2005-03-01 | 2011-08-31 | Tulip Medical Ltd | Biodegradable self-inflating intragastric implants and method of curbing appetite by the same |
US7785291B2 (en) * | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
US7736392B2 (en) * | 2005-04-28 | 2010-06-15 | Medtronic, Inc. | Bulking of upper esophageal sphincter for treatment of obesity |
US20060282107A1 (en) * | 2005-05-09 | 2006-12-14 | Kiyoshi Hashiba | Intragastric device for treating obesity |
US7691053B2 (en) * | 2005-05-20 | 2010-04-06 | Tyco Healthcare Group Lp | Gastric restrictor assembly and method of use |
US20060264982A1 (en) * | 2005-05-20 | 2006-11-23 | Viola Frank J | Gastric restrictor assembly and method of use |
US7666180B2 (en) * | 2005-05-20 | 2010-02-23 | Tyco Healthcare Group Lp | Gastric restrictor assembly and method of use |
US7976488B2 (en) | 2005-06-08 | 2011-07-12 | Gi Dynamics, Inc. | Gastrointestinal anchor compliance |
US7967818B2 (en) | 2005-06-10 | 2011-06-28 | Cook Medical Technologies Llc | Cautery catheter |
US9055942B2 (en) | 2005-10-03 | 2015-06-16 | Boston Scienctific Scimed, Inc. | Endoscopic plication devices and methods |
US8123768B2 (en) * | 2005-10-24 | 2012-02-28 | Gil Vardi | Method and system to restrict stomach size |
CN101365400A (en) * | 2005-11-10 | 2009-02-11 | 森迪奈尔集团有限责任公司 | Intraluminal and transluminal device and method of visualization and therapeutic intervention |
US8216268B2 (en) * | 2005-12-22 | 2012-07-10 | Cook Medical Technologies Llc | Intragastric bag for treating obesity |
EP1968506B1 (en) * | 2005-12-22 | 2011-09-14 | Wilson-Cook Medical Inc. | Coiled intragastric member for treating obesity |
US20070198039A1 (en) * | 2006-01-27 | 2007-08-23 | Wilson-Cook Medical, Inc. | Intragastric device for treating obesity |
JP4533858B2 (en) * | 2006-03-09 | 2010-09-01 | オリンパスメディカルシステムズ株式会社 | Ligation device |
US8556925B2 (en) | 2007-10-11 | 2013-10-15 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US20090287227A1 (en) * | 2006-04-19 | 2009-11-19 | Newell Matthew B | Minimally invasive ,methods for implanting obesity treatment devices |
US8342183B2 (en) | 2006-04-19 | 2013-01-01 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8070768B2 (en) | 2006-04-19 | 2011-12-06 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US7976554B2 (en) | 2006-04-19 | 2011-07-12 | Vibrynt, Inc. | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US8398668B2 (en) | 2006-04-19 | 2013-03-19 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8187297B2 (en) | 2006-04-19 | 2012-05-29 | Vibsynt, Inc. | Devices and methods for treatment of obesity |
US8585733B2 (en) | 2006-04-19 | 2013-11-19 | Vibrynt, Inc | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US20090281498A1 (en) * | 2006-04-19 | 2009-11-12 | Acosta Pablo G | Devices, system and methods for minimally invasive abdominal surgical procedures |
CA2652569C (en) * | 2006-05-18 | 2015-12-22 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric and non-gastric implants |
US8002731B2 (en) * | 2006-05-30 | 2011-08-23 | Boston Scientific Scimed, Inc. | Anti-obesity stent |
US7867283B2 (en) * | 2006-05-30 | 2011-01-11 | Boston Scientific Scimed, Inc. | Anti-obesity diverter structure |
US7922684B2 (en) * | 2006-05-30 | 2011-04-12 | Boston Scientific Scimed, Inc. | Anti-obesity dual stent |
CN101500517B (en) | 2006-06-05 | 2012-03-07 | 乔斯·拉斐尔·加尔扎·艾尔瓦热兹 | Intragastric balloon assembly |
US20110082442A1 (en) * | 2006-07-05 | 2011-04-07 | Solovay Kenneth S | Externally reinforced percutaneous gastrostomy tube with customizable smooth tube length |
AU2007269591A1 (en) * | 2006-07-05 | 2008-01-10 | Aspiration Medical Technology, Llc | Shunt apparatus for treating obesity by extracting food |
US8414561B2 (en) * | 2006-08-03 | 2013-04-09 | Aspire Bariatrics, Llc | Systems and methods for removing ingested material from a stomach |
US8632513B2 (en) * | 2006-08-03 | 2014-01-21 | Aspire Bariatrics, Inc. | Systems and methods for removing ingested material from a stomach |
US20080097510A1 (en) * | 2006-09-01 | 2008-04-24 | Albrecht Thomas E | Method for inducing weight loss with a patient |
US8109895B2 (en) | 2006-09-02 | 2012-02-07 | Barosense, Inc. | Intestinal sleeves and associated deployment systems and methods |
EP2068719B1 (en) | 2006-09-15 | 2017-10-25 | Boston Scientific Scimed, Inc. | System for anchoring stomach implant |
US7892250B2 (en) * | 2006-11-01 | 2011-02-22 | Ethicon Endo-Surgery, Inc. | Use of biosurgical adhesive on inflatable device for gastric restriction |
EP2066272A2 (en) | 2006-12-28 | 2009-06-10 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
WO2008147476A1 (en) * | 2007-01-23 | 2008-12-04 | Cvdevices, Llc | Devices, systems, and methods for endoscopic gastric magnetic restriction |
US8529431B2 (en) | 2007-02-14 | 2013-09-10 | Bfkw, Llc | Bariatric device and method |
WO2008100984A2 (en) | 2007-02-14 | 2008-08-21 | Sentinel Group, Llc | Mucosal capture fixation of medical device |
US8801647B2 (en) | 2007-02-22 | 2014-08-12 | Gi Dynamics, Inc. | Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks |
WO2008109527A2 (en) * | 2007-03-02 | 2008-09-12 | Wilson-Cook Medical Inc. | Apparatus and methods for delaying gastric emptying to treat obesity |
EP2134303A1 (en) * | 2007-03-29 | 2009-12-23 | Jaime Vargas | Intragastric implant devices |
US20080255678A1 (en) * | 2007-04-13 | 2008-10-16 | Cully Edward H | Medical apparatus and method of making the same |
US9717584B2 (en) * | 2007-04-13 | 2017-08-01 | W. L. Gore & Associates, Inc. | Medical apparatus and method of making the same |
US9642693B2 (en) * | 2007-04-13 | 2017-05-09 | W. L. Gore & Associates, Inc. | Medical apparatus and method of making the same |
US8007507B2 (en) * | 2007-05-10 | 2011-08-30 | Cook Medical Technologies Llc | Intragastric bag apparatus and method of delivery for treating obesity |
US8435203B2 (en) * | 2007-06-20 | 2013-05-07 | Covidien Lp | Gastric restrictor assembly and method of use |
US20090030284A1 (en) | 2007-07-18 | 2009-01-29 | David Cole | Overtube introducer for use in endoscopic bariatric surgery |
CA2696993C (en) | 2007-07-18 | 2017-01-03 | Samuel T. Crews | Endoscopic implant system and method |
WO2009033049A1 (en) * | 2007-09-07 | 2009-03-12 | Baronova, Inc. | Device for intermittently obstructing a gastric opening and method of use |
US20090149879A1 (en) * | 2007-12-10 | 2009-06-11 | Dillon Travis E | Dynamic volume displacement weight loss device |
US7883524B2 (en) * | 2007-12-21 | 2011-02-08 | Wilson-Cook Medical Inc. | Method of delivering an intragastric device for treating obesity |
US8016851B2 (en) * | 2007-12-27 | 2011-09-13 | Cook Medical Technologies Llc | Delivery system and method of delivery for treating obesity |
US20090171383A1 (en) | 2007-12-31 | 2009-07-02 | David Cole | Gastric space occupier systems and methods of use |
US10517709B2 (en) | 2008-02-01 | 2019-12-31 | Ballast Medical Inc. | Methods and devices for anchoring a gastroenterologic sleeve |
US8020741B2 (en) | 2008-03-18 | 2011-09-20 | Barosense, Inc. | Endoscopic stapling devices and methods |
US8100850B2 (en) * | 2008-04-09 | 2012-01-24 | E2 Llc | Pyloric valve devices and methods |
US8226593B2 (en) | 2008-04-09 | 2012-07-24 | E2 Llc | Pyloric valve |
EP2280670A4 (en) * | 2008-04-28 | 2012-08-01 | Eatlittle Inc | Bezoar-forming units for weight control |
US10603489B2 (en) | 2008-10-09 | 2020-03-31 | Virender K. Sharma | Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage |
US9079028B2 (en) | 2008-10-09 | 2015-07-14 | Virender K. Sharma | Method and apparatus for stimulating the vascular system |
US7934631B2 (en) | 2008-11-10 | 2011-05-03 | Barosense, Inc. | Multi-fire stapling systems and methods for delivering arrays of staples |
US8911346B2 (en) * | 2008-12-05 | 2014-12-16 | Onclomed, Inc. | Gastric restriction devices with fillable chambers and ablation means for treating obesity |
US8357081B2 (en) * | 2008-12-05 | 2013-01-22 | Onciomed, Inc. | Method and apparatus for gastric restriction of the stomach to treat obesity |
US20100249822A1 (en) * | 2009-03-31 | 2010-09-30 | Raj Nihalani | Method and apparatus for treating obesity and controlling weight gain using adjustable intragastric devices |
US8100932B2 (en) * | 2009-03-31 | 2012-01-24 | Onciomed, Inc. | Method and apparatus for treating obesity and controlling weight gain using self-expanding intragastric devices |
US9278019B2 (en) | 2009-04-03 | 2016-03-08 | Metamodix, Inc | Anchors and methods for intestinal bypass sleeves |
US8211186B2 (en) | 2009-04-03 | 2012-07-03 | Metamodix, Inc. | Modular gastrointestinal prostheses |
US8702641B2 (en) | 2009-04-03 | 2014-04-22 | Metamodix, Inc. | Gastrointestinal prostheses having partial bypass configurations |
US9173760B2 (en) | 2009-04-03 | 2015-11-03 | Metamodix, Inc. | Delivery devices and methods for gastrointestinal implants |
US8961539B2 (en) * | 2009-05-04 | 2015-02-24 | Boston Scientific Scimed, Inc. | Endoscopic implant system and method |
CN102470038A (en) | 2009-07-10 | 2012-05-23 | 美特默迪克斯公司 | External anchoring configurations for modular gastrointestinal prostheses |
US9173734B2 (en) | 2009-09-29 | 2015-11-03 | IBIS Medical, Inc. | Intragastric implant devices |
AU2010308498B2 (en) | 2009-10-21 | 2016-02-11 | Apollo Endosurgery, Inc. | Bariatric device and method for weight loss |
US20110118650A1 (en) * | 2009-11-18 | 2011-05-19 | Anteromed, Inc. | Method and apparatus for treating obesity and controlling weight gain and absorption of glucose in mammals |
US8608642B2 (en) * | 2010-02-25 | 2013-12-17 | Ethicon Endo-Surgery, Inc. | Methods and devices for treating morbid obesity using hydrogel |
CA2793367C (en) | 2010-03-15 | 2018-01-02 | Allergan, Inc. | Bariatric device and method for weight loss |
EP2552350A1 (en) | 2010-03-26 | 2013-02-06 | Ibis Medical Inc. | Intragastric implant devices |
WO2011136963A1 (en) | 2010-04-30 | 2011-11-03 | Boston Scientific Scimed, Inc. | Duodenal metabolic stent |
US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
WO2011159271A1 (en) * | 2010-06-13 | 2011-12-22 | Sharma Virender K | Intragastric device for treating obesity |
US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
US8628554B2 (en) * | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
WO2012011105A2 (en) | 2010-07-22 | 2012-01-26 | Pierre Sharvit | Pancreatiobiliary diversion device |
US9233016B2 (en) | 2010-10-18 | 2016-01-12 | Apollo Endosurgery, Inc. | Elevating stomach stimulation device |
ES2566498T3 (en) | 2010-10-18 | 2016-04-13 | Apollo Endosurgery, Inc. | Intragastric implants with duodenal anchors |
US8870966B2 (en) | 2010-10-18 | 2014-10-28 | Apollo Endosurgery, Inc. | Intragastric balloon for treating obesity |
WO2012054519A2 (en) | 2010-10-18 | 2012-04-26 | Allergan, Inc. | Reactive intragastric implant devices |
US9463107B2 (en) | 2010-10-18 | 2016-10-11 | Apollo Endosurgery, Inc. | Variable size intragastric implant devices |
US9095405B2 (en) | 2010-10-19 | 2015-08-04 | Apollo Endosurgery, Inc. | Space-filling intragastric implants with fluid flow |
US8920447B2 (en) * | 2010-10-19 | 2014-12-30 | Apollo Endosurgery, Inc. | Articulated gastric implant clip |
US8864840B2 (en) | 2010-10-19 | 2014-10-21 | Apollo Endosurgery, Inc. | Intragastric implants with collapsible frames |
US9198790B2 (en) | 2010-10-19 | 2015-12-01 | Apollo Endosurgery, Inc. | Upper stomach gastric implants |
US9498365B2 (en) | 2010-10-19 | 2016-11-22 | Apollo Endosurgery, Inc. | Intragastric implants with multiple fluid chambers |
US20120095497A1 (en) * | 2010-10-19 | 2012-04-19 | Allergan, Inc. | Non-inflatable gastric implants and systems |
ES2593753T3 (en) | 2010-10-19 | 2016-12-13 | Apollo Endosurgery, Inc. | Duodenal sleeve with anchor without perforation |
US9398969B2 (en) | 2010-10-19 | 2016-07-26 | Apollo Endosurgery, Inc. | Upper stomach gastric implants |
WO2012162114A1 (en) | 2011-05-20 | 2012-11-29 | Bfkw, Llc | Intraluminal device and method with enhanced anti-migration |
US8382775B1 (en) | 2012-01-08 | 2013-02-26 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
US9314362B2 (en) | 2012-01-08 | 2016-04-19 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
US8706234B2 (en) | 2012-02-21 | 2014-04-22 | Virender K. Sharma | System and method for electrical stimulation of anorectal structures to treat anal dysfunction |
US10576278B2 (en) | 2012-02-21 | 2020-03-03 | Virender K. Sharma | System and method for electrical stimulation of anorectal structures to treat urinary dysfunction |
US9782583B2 (en) | 2012-02-21 | 2017-10-10 | Virender K. Sharma | System and method for electrical stimulation of anorectal structures to treat urinary dysfunction |
US9545326B2 (en) | 2012-03-06 | 2017-01-17 | Bfkw, Llc | Intraluminal device delivery technique |
CN104334123B (en) | 2012-06-07 | 2019-02-12 | 意比图密医疗有限公司 | Expansion device |
WO2014113483A1 (en) | 2013-01-15 | 2014-07-24 | Metamodix, Inc. | System and method for affecting intestinal microbial flora |
JP6333862B2 (en) | 2013-02-23 | 2018-05-30 | アスパイア・バリアトリックス・インコーポレーテッド | Device and method for draining material from the stomach |
US9743987B2 (en) | 2013-03-14 | 2017-08-29 | Board Of Regents Of The University Of Nebraska | Methods, systems, and devices relating to robotic surgical devices, end effectors, and controllers |
WO2014153267A2 (en) * | 2013-03-14 | 2014-09-25 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US9764067B2 (en) | 2013-03-15 | 2017-09-19 | Boston Scientific Scimed, Inc. | Superhydrophobic coating for airway mucus plugging prevention |
BR112015023344B1 (en) | 2013-03-15 | 2022-05-31 | Baronova, Inc | Device for intermittently occluding a gastric opening; and reconfiguration method installing an occlusion device |
US11129793B2 (en) | 2013-12-05 | 2021-09-28 | Epitomee Medical Ltd | Retentive devices and systems for in-situ release of pharmaceutical active agents |
US20150223956A1 (en) * | 2014-02-12 | 2015-08-13 | Children's National Medical Center | Anchored non-spherical balloon for the treatment of obesity |
US10383756B2 (en) * | 2014-03-14 | 2019-08-20 | Boston Scientific Scimed, Inc. | Intragastric balloon delivery systems and methods |
KR102051719B1 (en) * | 2014-09-23 | 2019-12-03 | 시너지 메디칼, 인크. | Intragastric device for treating obesity |
US11013629B2 (en) | 2014-12-29 | 2021-05-25 | Bfkw, Llc | Fixation of intraluminal device |
US10682219B2 (en) | 2014-12-29 | 2020-06-16 | Bfkw, Llc | Fixation of intraluminal device |
US11020213B2 (en) | 2014-12-29 | 2021-06-01 | Bfkw, Llc | Fixation of intraluminal device |
JP6574313B2 (en) * | 2015-09-23 | 2019-09-11 | サイナーズ メディカル,インコーポレイティド | Intragastric device for the treatment of obesity |
US9622897B1 (en) | 2016-03-03 | 2017-04-18 | Metamodix, Inc. | Pyloric anchors and methods for intestinal bypass sleeves |
US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US10751209B2 (en) | 2016-05-19 | 2020-08-25 | Metamodix, Inc. | Pyloric anchor retrieval tools and methods |
US10722319B2 (en) | 2016-12-14 | 2020-07-28 | Virtual Incision Corporation | Releasable attachment device for coupling to medical devices and related systems and methods |
US10537454B2 (en) * | 2017-06-16 | 2020-01-21 | Proximate Concepts Llc | Electrophysiologically active transducer intragastric balloon system and method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6461631B1 (en) * | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
US6675809B2 (en) * | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
US6755869B2 (en) * | 2001-11-09 | 2004-06-29 | Boston Scientific Corporation | Intragastric prosthesis for the treatment of morbid obesity |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4648383A (en) * | 1985-01-11 | 1987-03-10 | Angelchik Jean P | Peroral apparatus for morbid obesity treatment |
US5306300A (en) * | 1992-09-22 | 1994-04-26 | Berry H Lee | Tubular digestive screen |
-
2002
- 2002-01-25 US US10/057,469 patent/US6755869B2/en not_active Expired - Lifetime
-
2004
- 2004-03-08 US US10/795,491 patent/US7090699B2/en not_active Expired - Fee Related
-
2006
- 2006-08-10 US US11/503,538 patent/US7799088B2/en not_active Expired - Fee Related
-
2010
- 2010-08-30 US US12/870,977 patent/US8142514B2/en not_active Expired - Lifetime
-
2012
- 2012-02-29 US US13/408,578 patent/US20120165955A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6461631B1 (en) * | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
US6675809B2 (en) * | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
US6755869B2 (en) * | 2001-11-09 | 2004-06-29 | Boston Scientific Corporation | Intragastric prosthesis for the treatment of morbid obesity |
US7090699B2 (en) * | 2001-11-09 | 2006-08-15 | Boston Scientific Corporation | Intragastric prosthesis for the treatment of morbid obesity |
US7799088B2 (en) * | 2001-11-09 | 2010-09-21 | Boston Scientific Scimed, Inc. | Intragastric prosthesis for the treatment of morbid obesity |
US8142514B2 (en) * | 2001-11-09 | 2012-03-27 | Boston Scientific Scimed, Inc. | Intragastric prosthesis for the treatment of morbid obesity |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120004590A1 (en) * | 2003-01-16 | 2012-01-05 | Barosense, Inc | Satiation pouches and methods of use |
US9358145B2 (en) | 2003-01-16 | 2016-06-07 | Boston Scientific Scimed, Inc. | Satiation pouches and methods of use |
US9827130B2 (en) | 2003-01-16 | 2017-11-28 | Boston Scientific Scimed, Inc. | Implantable devices having a radially expandable barrier and related methods of use |
Also Published As
Publication number | Publication date |
---|---|
US20100324696A1 (en) | 2010-12-23 |
US8142514B2 (en) | 2012-03-27 |
US7799088B2 (en) | 2010-09-21 |
US6755869B2 (en) | 2004-06-29 |
US20030109935A1 (en) | 2003-06-12 |
US20040172143A1 (en) | 2004-09-02 |
US20070038308A1 (en) | 2007-02-15 |
US7090699B2 (en) | 2006-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7799088B2 (en) | Intragastric prosthesis for the treatment of morbid obesity | |
US6946002B2 (en) | Intragastric stent for duodenum bypass | |
US11197774B2 (en) | Devices and methods for gastrointestinal stimulation | |
US9254214B2 (en) | Satiation devices and methods | |
EP1978876B1 (en) | Devices for gastrointestinal stimulation | |
US7776061B2 (en) | Fluid adjustable band | |
US7047981B2 (en) | Implant system and method for bulking tissue | |
US8007507B2 (en) | Intragastric bag apparatus and method of delivery for treating obesity | |
US20240108486A1 (en) | Systems and methods for anchoring and restraining gastrointestinal prostheses | |
US20220117766A1 (en) | Obesity treatment devices, systems, and methods | |
US20210244557A1 (en) | Systems and method for stabilizing anti-migration anchor system | |
US20100114148A1 (en) | Devices and methods for adjusting a satiation and satiety-inducing implanted device | |
EP3597156B1 (en) | Gastrointestinal implant and method for deploying the same | |
CA3217104A1 (en) | Systems and method for stabilizing anti-migration anchor system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC CORPORTION;REEL/FRAME:027913/0770 Effective date: 20100429 Owner name: BOSTON SCIENTIFIC CORPORATION, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GEITZ, KURT;REEL/FRAME:027913/0604 Effective date: 20020328 |
|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC CORPORATION, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GEITZ, KURT;REEL/FRAME:032454/0452 Effective date: 20020328 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |